Krish Biomedicals Industry Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -56.13%
- Profit Growth -241.76%
- Ebitda -211.53%
- Net Worth -200.94%
- Total Assets 76.98%
About Krish Biomedicals Industry
Krish Biomedicals Industry Private Limited (KBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 October 2012 and has a history of 12 years and three months. Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Corporate was formerly known as S.J. Designers Cloths Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sharad Jain and Sangeeta Jain serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U18204UP2012PTC053095
-
Company No.
053095
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Oct 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Krish Biomedicals Industry?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharad Jain
|
Director | 01-May-2017 | Current |
|
Sangeeta Jain
|
Director | 01-May-2017 | Current |
Financial Performance of Krish Biomedicals Industry.
Krish Biomedicals Industry Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 56.13% decrease. The company also saw a substantial fall in profitability, with a 241.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 200.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krish Biomedicals Industry?
In 2022, Krish Biomedicals Industry had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Krish Biomedicals (India) Private LimitedSharad Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Krish Biomedicals Industry?
Unlock and access historical data on people associated with Krish Biomedicals Industry, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krish Biomedicals Industry, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krish Biomedicals Industry's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
